Groowe Groowe / Newsroom / SNY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

SNY News

Sanofi American Depositary Shares (Each representing one-half of one ordinary share)

Press Release: Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector

globenewswire.com
SNY

Forbion Expands Global Investment Leadership with Senior Promotions and Appointment of Operating Partner

globenewswire.com
SNY REGN BIIB INSM

IgE Receptor Antagonists Clinical Trial Pipeline Analysis: 12+ Key Companies Shaping the Future of IgE Receptor Antagonists Therapeutics | DelveInsight

globenewswire.com
AMRX ARX GSK AZN SNY NVS MRK REGN JNJ PFE BMY LLY VRTX AMGN ABBV GILD BIIB CSL AQST RAPT ALGT

Press Release: Sanofi launches 2026 global employee stock purchase plan

globenewswire.com
SNY

HSBC Continental Europe: Post Stabilisation Notice

globenewswire.com
SNY HSBC

Global Drug Discovery Market Projected to Surpass USD 174.92 Billion by 2035 – SNS Insider

globenewswire.com
MRK AZN SNY ROG NVS

Press Release: Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease

globenewswire.com
SNY

Biomunex Announces Strategic Artificial Intelligence Collaborations to Further Accelerate the Discovery and Development Processes of Its Innovative Pipeline of Cancer Immunotherapies

businesswire.com
SNY

NMDP Gala in New York City Raises Record-Breaking $660,000 Enabling More Patients to Receive Life-Saving Cell Therapy

globenewswire.com
SNY MSB AMZN MRK

GLP-1 Receptor Agonist Market Report 2026

globenewswire.com
NVO SNY LLY